Literature DB >> 19676115

Structural insights into recognition of beta2-glycoprotein I by the lipoprotein receptors.

Dmitri Beglov1, Chang-Jin Lee, Alfredo De Biasio, Dima Kozakov, Ryan Brenke, Sandor Vajda, Natalia Beglova.   

Abstract

The interactions of beta2 glycoprotein I (B2GPI) with the receptors of the low-density lipoprotein receptor (LDLR) family are implicated in the clearance of negatively charged phospholipids and apoptotic cells and, in the presence of autoimmune anti-B2GPI antibodies, in cell activation, which might play a role in the pathology of antiphospholipid syndrome (APS). The ligand-binding domains of the lipoprotein receptors consist of multiple homologous LA modules connected by flexible linkers. In this study, we investigated at the atomic level the features of the LA modules required for binding to B2GPI. To compare the binding interface in B2GPI/LA complex to that observed in the high-resolution co-crystal structure of the receptor associated protein (RAP) with a pair of LA modules 3 and 4 from the LDLR, we used LA4 in our studies. Using solution NMR spectroscopy, we found that LA4 interacts with B2GPI and the binding site for B2GPI on the (15)N-labeled LA4 is formed by the calcium coordinating residues of the LA module. We built a model for the complex between domain V of B2GPI (B2GPI-DV) and LA4 without introducing any experimentally derived constraints into the docking procedure. Our model, which is in the agreement with the NMR data, suggests that the binding interface of B2GPI for the lipoprotein receptors is centered at three lysine residues of B2GPI-DV, Lys 308, Lys 282, and Lys317. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19676115      PMCID: PMC2767435          DOI: 10.1002/prot.22519

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  50 in total

1.  Structure of the LDL receptor extracellular domain at endosomal pH.

Authors:  Gabby Rudenko; Lisa Henry; Keith Henderson; Konstantin Ichtchenko; Michael S Brown; Joseph L Goldstein; Johann Deisenhofer
Journal:  Science       Date:  2002-11-29       Impact factor: 47.728

2.  Binding site structure of one LRP-RAP complex: implications for a common ligand-receptor binding motif.

Authors:  Gitte A Jensen; Olav M Andersen; Alexandre M J J Bonvin; Ida Bjerrum-Bohr; Michael Etzerodt; Hans C Thøgersen; Charlotte O'Shea; Flemming M Poulsen; Birthe B Kragelund
Journal:  J Mol Biol       Date:  2006-07-15       Impact factor: 5.469

Review 3.  Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome.

Authors:  Rolf T Urbanus; Ronald H M W Derksen; Philip G de Groot
Journal:  Blood Rev       Date:  2007-10-25       Impact factor: 8.250

4.  NMR solution structure of the receptor binding domain of human alpha(2)-macroglobulin.

Authors:  W Huang; K Dolmer; X Liao; P G Gettins
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

5.  The binding site in {beta}2-glycoprotein I for ApoER2' on platelets is located in domain V.

Authors:  Menno van Lummel; Maarten T T Pennings; Ronald H W M Derksen; Rolf T Urbanus; Bianca C H Lutters; Niels Kaldenhoven; Philip G de Groot
Journal:  J Biol Chem       Date:  2005-08-09       Impact factor: 5.157

6.  Specific binding of alpha-macroglobulin to complement-type repeat CR4 of the low-density lipoprotein receptor-related protein.

Authors:  O M Andersen; P A Christensen; L L Christensen; C Jacobsen; S K Moestrup; M Etzerodt; H C Thogersen
Journal:  Biochemistry       Date:  2000-09-05       Impact factor: 3.162

Review 7.  Current concepts on the pathogenesis of the antiphospholipid syndrome.

Authors:  Bill Giannakopoulos; Freda Passam; Soheila Rahgozar; Steven A Krilis
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

8.  Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome.

Authors:  R Schwarzenbacher; K Zeth; K Diederichs; A Gries; G M Kostner; P Laggner; R Prassl
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

9.  Circulating levels of beta2-glycoprotein I in thrombotic disorders and in inflammation.

Authors:  F Lin; R Murphy; B White; J Kelly; C Feighery; R Doyle; S Pittock; J Moroney; O Smith; W Livingstone; C Keenan; J Jackson
Journal:  Lupus       Date:  2006       Impact factor: 2.911

10.  1H, 13C and 15N chemical shift referencing in biomolecular NMR.

Authors:  D S Wishart; C G Bigam; J Yao; F Abildgaard; H J Dyson; E Oldfield; J L Markley; B D Sykes
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

View more
  5 in total

1.  SorLA complement-type repeat domains protect the amyloid precursor protein against processing.

Authors:  Arnela Mehmedbasic; Sofie K Christensen; Jonas Nilsson; Ulla Rüetschi; Camilla Gustafsen; Annemarie Svane Aavild Poulsen; Rikke W Rasmussen; Anja N Fjorback; Göran Larson; Olav M Andersen
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

2.  A novel dimeric inhibitor targeting Beta2GPI in Beta2GPI/antibody complexes implicated in antiphospholipid syndrome.

Authors:  Alexey Kolyada; Chang-Jin Lee; Alfredo De Biasio; Natalia Beglova
Journal:  PLoS One       Date:  2010-12-15       Impact factor: 3.240

3.  Structural basis of transcobalamin recognition by human CD320 receptor.

Authors:  Amer Alam; Jae-Sung Woo; Jennifer Schmitz; Bernadette Prinz; Katharina Root; Fan Chen; Joël S Bloch; Renato Zenobi; Kaspar P Locher
Journal:  Nat Commun       Date:  2016-07-14       Impact factor: 14.919

4.  Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein.

Authors:  Jovan Nikolic; Laura Belot; Hélène Raux; Pierre Legrand; Yves Gaudin; Aurélie A Albertini
Journal:  Nat Commun       Date:  2018-03-12       Impact factor: 14.919

5.  Interactions between Hepatitis C Virus and the Human Apolipoprotein H Acute Phase Protein: A Tool for a Sensitive Detection of the Virus.

Authors:  Ilias Stefas; Sylvia Tigrett; Grégor Dubois; Marco Kaiser; Estelle Lucarz; Delphine Gobby; Dorothy Bray; Heinz Ellerbrok; Jean Pierre Zarski; Francisco Veas
Journal:  PLoS One       Date:  2015-10-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.